Design Therapeutics Inc (NAS:DSGN)
$ 6.35 0.14 (2.25%) Market Cap: 359.54 Mil Enterprise Value: 107.99 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 40/100

Design Therapeutics Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript

Aug 10, 2022 / 02:20PM GMT
Release Date Price: $23.3 (+5.96%)
Laura Chico;JoÃ;o Siffert<
Wedbush PacGrow Inc. - Analyst

Thanks, everybody, for joining us. My name is Laura Chico, one of the senior analyst here at Wedbush. It is my great pleasure to introduce our next presenting company design therapeutics. I'm really excited today to be hosting from Design CEO, João Siffert, and Chief Business Officer -- Chief Operating Officer, Sean Jeffries. Thank you gentlemen for joining us today. I'm going to hand it over to João Siffert here.

But before we kick off, I just wanted to remind the audience that we would love to get some participation. There is a chat box at the bottom of your screen. We would love free to answer any questions that you might have for the team here. We will get them asked, but without further ado, Design is a newer entrant to the public biotech markets. And since you completed your IPO in 2021, for those in our audience, that might be a little bit less familiar with the story. Would love for you to give us a brief introduction to the company, the GeneTAC platform, and some of your upcoming milestones.

£

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot